IQV IQV IQVIAホ―ルディングス

 IQVのチャート


 IQVの企業情報

symbol IQV
会社名 IQVIA Holdings Inc (IQV IQVIAホ―ルディングス)
分野(sector)   
産業(industry)   
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 事業概要 IQVIA・ホルディングス(IQVIA Holdings Inc.)(旧名:Quintiles IMS Holdings Inc.)は統合情報と技術対応の医療サービスを提供する。同社は3つの事業セグメントを運営する。商業ソリューション事業は国家と地方情報、技術ソリューション、ワークフロー分析とコンサルティングサービスを提供する。研究・開発ソリューション事業はバイオ医薬品開発サービスを提供する。同事業はプロジェクト管理、臨床モニタリング、臨床試験サポートサービス、クインタイルズとクエスト(Q2)ソリューション及び戦略的計画・設計等を提供する。統合エンゲージメント・サービス事業は医療供給者エンゲージメントサービス、患者エンゲージメントサービス及び科学戦略、医療業務サービスを提供する。同社の事業は米州、欧州とアフリカ、及びアジア太平洋地域に展開される。  IQVIAホ―ルディングスは米国のライフサイエンス企業。ヘルスケア産業を対象に医療・ヘルスケア情報およびサイエンスによるテクノロジ―ソリュ―ションを提供する。主にバイオ医薬品企業に対し臨床研究および臨床試験サ―ビスを提供するほか、ヘルスケア企業のマ―ケティング・販売戦略支援や、マネジメントコンサルティングを行う。  IQVIA Holdings, Inc. operates as a biotechnology company. It engages in healthcare development in the provision of professional services, information technology, and partnering solutions. It operates through the following segments: Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment provides mission critical information, technology solutions and real world solutions and services to the firm's life science clients. Research & Development Solutions segment, which primarily serves biopharmaceutical customers, provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment provides health care provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1982 and is headquartered in Durham, NC.
本社所在地 919 998-2000
代表者氏名 Ari Bousbib
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 919-998-2000
設立年月日 1982年
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 58000人
url www.quintiles.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 1950.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 28453.43000
売上高 売上高(百万ドル) 10412.00000
企業価値(EV) 企業価値(EV)(百万ドル) 38522.43000
当期純利益 当期純利益(百万ドル) 224.00000
決算概要 決算概要 BRIEF: For the fiscal year ended 31 December 2018 Iqvia Holdings Inc revenues increased 7% to $10.41B. Net income before extraordinary items decreased 28% to $224M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income was offset by Other segment loss increase of 13% to $1.14B Contract Sales_Medical Solutions segment income decrease of 20% to $59M.

 IQVのテクニカル分析


 IQVのニュース

   IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript | AlphaStreet  2020/07/23 01:11:54 News Alphastreet
IQVIA Holdings Inc. (NYSE: IQV) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Andrew Markwick -- Senior Vice President, Investor Relations
   IQVIA Holdings: Q2 Earnings Insights  2020/07/22 07:58:00 Benzinga
Shares of IQVIA Holdings (NYSE:IQV) fell 1.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 22.88% …
   Biogen Taps Iqvia CFO as New Finance Chief -- Update | MarketScreener  2020/07/22 00:50:01 MarketScreener
By Kimberly Chin and Kristin Broughton Drugmaker Biogen Inc. has named Michael McDonnell, the current finance chief at drug-testing and data company Iqvia Holdings Inc., as its next chief… | July 22, 2020
   IQVIA : Says Working With AstraZeneca to Accelerate Potential Covid-19 Vaccine | MarketScreener  2020/07/14 13:01:02 MarketScreener
By Michael Dabaie IQVIA Holdings Inc. said it is working with AstraZeneca PLC to accelerate development of a potential vaccine for Covid-19. IQVIA, a provider of analytics, technology… | July 14, 2020
   IQVIA UK Regulatory Announcement: IQVIA Announces Pricing of Offering of Senior Notes  2020/06/11 06:00:00 Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €711,000
   IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript | AlphaStreet  2020/07/23 01:11:54 News Alphastreet
IQVIA Holdings Inc. (NYSE: IQV) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Andrew Markwick -- Senior Vice President, Investor Relations
   IQVIA Holdings: Q2 Earnings Insights  2020/07/22 07:58:00 Benzinga
Shares of IQVIA Holdings (NYSE:IQV) fell 1.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 22.88% …
   Biogen Taps Iqvia CFO as New Finance Chief -- Update | MarketScreener  2020/07/22 00:50:01 MarketScreener
By Kimberly Chin and Kristin Broughton Drugmaker Biogen Inc. has named Michael McDonnell, the current finance chief at drug-testing and data company Iqvia Holdings Inc., as its next chief… | July 22, 2020
   IQVIA : Says Working With AstraZeneca to Accelerate Potential Covid-19 Vaccine | MarketScreener  2020/07/14 13:01:02 MarketScreener
By Michael Dabaie IQVIA Holdings Inc. said it is working with AstraZeneca PLC to accelerate development of a potential vaccine for Covid-19. IQVIA, a provider of analytics, technology… | July 14, 2020
   IQVIA UK Regulatory Announcement: IQVIA Announces Pricing of Offering of Senior Notes  2020/06/11 06:00:00 Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €711,000
   IQVIA Holdings Inc. (IQV) Q2 2020 Earnings Call Transcript | AlphaStreet  2020/07/23 01:11:54 News Alphastreet
IQVIA Holdings Inc. (NYSE: IQV) Q2 2020 earnings call dated July 22, 2020 Corporate Participants: Andrew Markwick -- Senior Vice President, Investor Relations
   IQVIA Holdings: Q2 Earnings Insights  2020/07/22 07:58:00 Benzinga
Shares of IQVIA Holdings (NYSE:IQV) fell 1.6% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share fell 22.88% …
   Biogen Taps Iqvia CFO as New Finance Chief -- Update | MarketScreener  2020/07/22 00:50:01 MarketScreener
By Kimberly Chin and Kristin Broughton Drugmaker Biogen Inc. has named Michael McDonnell, the current finance chief at drug-testing and data company Iqvia Holdings Inc., as its next chief… | July 22, 2020
   IQVIA : Says Working With AstraZeneca to Accelerate Potential Covid-19 Vaccine | MarketScreener  2020/07/14 13:01:02 MarketScreener
By Michael Dabaie IQVIA Holdings Inc. said it is working with AstraZeneca PLC to accelerate development of a potential vaccine for Covid-19. IQVIA, a provider of analytics, technology… | July 14, 2020
   IQVIA UK Regulatory Announcement: IQVIA Announces Pricing of Offering of Senior Notes  2020/06/11 06:00:00 Business Wire
IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV) today announced that its wholly owned subsidiary, IQVIA Inc. (the “Issuer”), priced an offering of €711,000

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 IQV IQVIAホ―ルディングス IQV )

 twitter  (公式ツイッターやCEOツイッターなど)